FY2012 · ended Dec 31, 2012 · Revenue $616,338, -42.3% YoY · Filed Apr 1, 2013
Novelstem International Corp. (NSTM) files with the SEC under industry code 5990, Retail-Retail Stores, NEC. As of Jun 30, 2026 it held $56,235 in cash and investments and $1.4 million in total debt.
Revenue (TTM)
$510,701
-22.1% vs year-ago TTM
Net income
$2.38M
+173.6% vs prior year
Operating cash flow (TTM)
$-229,486
-8.1% vs year-ago TTM
Free cash flow
$-4.00M
-48.9% vs prior year
EPS
$0.05
+171.4% vs prior year
Dividend per share
None
Shares outstanding
49.33M
+5.2% vs prior year
Net cash
$-1.31M
as of Jun 30, 2026
Operating margin
-1175.4%
FY 2013
Company profile
- Industry
- Retail-Retail Stores, NEC (SIC 5990)
- Listed as
- NSTM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 912544
- Former names
- NovelStem International Corp (until Aug 2, 2022); HOLLYWOOD MEDIA CORP (until May 12, 2014); HOLLYWOOD COM INC (until Aug 14, 2000); BIG ENTERTAINMENT INC (until Mar 30, 2000)
Other Retail-Retail Stores, NEC companies
- JD.com, Inc. JD
- Ulta Beauty, Inc. ULTA
- Bath & Body Works, Inc. BBWI
- Sally Beauty Holdings, Inc. SBH
- ATRenew Inc. RERE
- Petco Health & Wellness Company, Inc. WOOF
- Titan Machinery Inc. TITN
- Star Group, L.P. SGU
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2012 Dec 31, 2012 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $616,338 |
| Operating income | -$238,755 | -$927,922 | -$3.5M | -$422,434 | -$5.7M |
| Net income | $2.4M | -$3.2M | -$4.2M | -$765,730 | $10.4M |
| Diluted EPS | $0.05 | -$0.07 | -$0.09 | — | — |
| Operating cash flow | -$167,633 | -$271,964 | -$348,283 | -$182,320 | -$3.9M |
| Free cash flow | — | — | — | — | -$4.0M |
| Total assets | $15,786 | $160,111 | $2.3M | $2.3M | $26.6M |
| Total liabilities | $2.2M | $5.3M | $4.2M | $353,326 | $1.7M |
| Stockholders' equity | -$2.1M | -$5.1M | -$2.0M | $1.9M | $25.0M |
| Cash and investments | $333 | — | $53,063 | $6,346 | $11.4M |
| Total debt | $1.3M | $4.1M | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 19, 2025 | Mar 31, 2025 |
All 555 Novelstem International Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.